薬物による男性不妊症:FAERSとEudraVigilanceのデータベースを使用した現実世界の研究
Zhuozhi Gong1, Jing He2, Qiujian Feng1
1Department of Andrology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Frontiers in pharmacology
|February 16, 2026
まとめ
この研究では,ホルモン剤や抗うつ剤を含む,男性不妊の原因となる可能性のある19の高リスク薬が特定されました. 生殖年齢の男性は,不妊カウンセリングを受け,これらの薬を始める前に精子の冷凍保存を検討する必要があります.
科学分野:
- 医薬品警戒と生殖毒理学について
- 薬物安全性およびリスク評価
背景:
- 男性不妊症はますます懸念される問題であり,薬剤の副作用が潜在的な要因である.
- 男性の生殖に毒性をもたらす薬物の体系的な特定は,臨床実務において極めて重要です.
研究 の 目的:
- 男性不妊症や精子異常を引き起こす可能性のある医薬品を体系的に特定する.
- 薬物による男性不妊症に関する臨床実務のためのリスクアラートを提供すること.
主な方法:
- FAERSとEudraVigilanceのデータベース (2002年-2025年) の医薬品監視データを活用した.
- MedDRAを使用して男性の生殖に有害な有害性の不良事件をスクリーニングし,信号検出のためにROR,PRR,IC,EBGMを使用しました.
- クロスデータベースの検証とデチャレンジ/再チャレンジ分析により信頼性が向上します.
主要な成果:
- 1,955件のFAERS症例と1,384件のEudraVigilance症例を分析し,37%が生殖年齢の男性を対象とした.
- ホルモン剤 (フィナステリド,テストステロン),抗新生剤,抗うつ剤を含む19種類の高リスク薬が特定されました.
- フィナステリドは,デチャレンジ/再チャレンジによる強い因果関係を示す証拠を示し,シグナルは尿生殖器系,皮膚科,抗腫瘍性カテゴリーに集中した.
結論:
- ホルモン剤,抗新生剤,抗うつ剤を含む男性不妊症に対する高リスク薬の19種類を特定しました.
- 処方前の受精カウンセリングと生殖年齢の男性に対するリスクの階層化の必要性を強調しています.
- 化学療法前に精子の冷凍保存を推奨し,5α-リドゥクタゼ阻害剤などの特定の薬剤の選択的検討を推奨する.
関連する概念動画
Infertility in Males
584
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
584
Pharmacovigilance
1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
Infertility in Females
4.9K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
4.9K
Bioavailability Study Design: Healthy Subjects Versus Patients
164
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
164
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
282
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
282
Spermatogenesis
123.8K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
123.8K


